Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Pharmacology in Human Cancers
NCT03477162Phase 1Terminated
- Sponsor
- Dartmouth Health
- Start
- May 2018
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of metformin in thoracic neoplasm, sponsored by Dartmouth Health. Primary endpoint: Lung Tumor Tissue Concentration of Metformin. Started May 2018; status: terminated.
02
Drugs
metformin
03
Conditions
thoracic neoplasm
Beyond the preview
Go deeper on NCT03477162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03477162.